Comparison

Thalidomide-NH-CH2-COOH (TFA) European Partner

Item no. HY-131717A-10mg
Manufacturer MedChem Express
CASRN 2377032-39-6
Amount 10 mg
Quantity options 1 ea 10 mg 1 mg 25 mg 50 mg 5 mg
Category
Type Standard
Specific against other
Citations [1]Calla M Olson, et al. Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation. Nat Chem Biol. 2018 Feb;14(2):163-170.|[2]Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
Smiles O=C(O)CNC1=CC=CC(C(N2C(CC3)C(NC3=O)=O)=O)=C1C2=O.O=C(C(F)(F)F)O
ECLASS 10.1 42021590
ECLASS 11.0 42021590
UNSPSC 12352202
Shipping condition Room temperature
Available
Manufacturer - Type
Reference compound
Manufacturer - Applications
Cancer-programmed cell death
Manufacturer - Targets
E3 Ligase Ligand-Linker Conjugates
Shipping Temperature
Room temperature
Molecular Weight
445.30
Product Description
Thalidomide-NH-CH2-COOH TFA is a ligand-linker conjugate for the E3 ligase Cereblon (CRBN). Thalidomide-NH-CH2-COOH TFA can be conjugated to multi-targeted kinase inhibitors to transform them into selective degraders [1] [2] .
Manufacturer - Research Area
Cancer
Manufacturer - Pathway
PROTAC
Clinical information
No Development Reported

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close